Intraperitoneal infectious complications Intraperitoneal infectious complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Pathologically diagnosed gastric adenocarcinoma 2)Laparoscopic/Robotic distal gastrectomy or total gastrectomy was performed 3)Clinical Stage I - III 4)Aged 18 - 85 years 5)Male and Female 6)ECOG Performance Status (PS) 0-1 7)Written informed consent was obtained
Exclusion criteria
Exclusion criteria: 1)Distant metastasis, invasion to other organs, or spread to esophagus 2)Neoadjuvant chemotherapy 3)Past history of irradiation to upper abdomen 4)Past history of upper abdominal surgery 5)Combined surgery for other diseases other than cholecystectomy 6)Severe infectious disease or other comorbidities 7)Sever drug allergy 8)Immune-suppressing drug or steroid use 9)Peritoneal dialysis or Hemodialysis 10)Multiple antiplatelet/ anticoagulant drug use or warfarin use 11)Pregnancy or suspected pregnancy 12)Others
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of intraoperative infectious complications (Clavien-Dindo grade >=III) | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of overall complication (Clavien-Dindo grade >=III) Incidence of pancreatic fistula (Clavien-Dindo grade >=III) Incidence of anastomotic leakage (Clavien-Dindo grade >=III) | — |
Contacts
Kyoto University Hospital